The PTPN22R620W polymorphism does not confer genetic susceptibility to antiphospholipid syndrome in the Spanish population

International Journal of Immunogenetics

Volumn 38, Issue 6, 2011, Pages 529-531

  Castro Marrero, J ^a   Balada, E ^a   Vilardell Tarres M ^a   Ordi Ros, J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PHOSPHOLIPID ANTIBODY; PTPN22 PROTEIN, HUMAN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; FEMALE; FETUS WASTAGE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTOPENIA; AMINO ACID SUBSTITUTION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MIDDLE AGED; POPULATION GENETICS; SPAIN;

AMINO ACID SUBSTITUTION; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; SPAIN;

EID: 80855130500     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2011.01038.x     Document Type: Article

References (11)

1. Balada, E., Ordi-Ros, J., Paredes, F., Villarreal, J., Mauri, M. & Vilardell-Tarrés, M. (2001) Antiphosphatidylethanolamine antibodies contribute to the diagnosis of antiphospholipid syndrome in patients with systemic lupus erythematosus. Scandinavian Journal of Rheumatology, 30, 235.
2. Balada, E., Villarreal-Tolchinsky, J., Ordi-Ros, J., Labrador, M., Serrano-Acedo, S. & Martinez-Lostao, L. (2006) Multiplex family-based study in systemic lupus erythematosus: association between the R620W polymorphism of PTPN22 and the FcgammaRIIa (CD32A) R131 allele. Tissue Antigens, 68, 432.
3. Bottini, N., Vang, T., Cucca, F. & Mustelin, T. (2006) Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Seminars in Immunology, 18, 207.
4. Carlton, V.E., Hu, X., Chokkalingam, A.P., Schrodi, S.J., Brandon, R., Alexander, H.C. et al. (2005) PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. American Journal of Human Genetics, 77, 567.
5. Chung, S.A. & Criswell, L.A. (2007) PTPN22: its role in SLE and autoimmunity. Autoimmunity, 40, 582.
6. Gregersen, P.K., Lee, H.S., Batliwalla, F. & Begovich, A.B. (2006) PTPN22: setting thresholds for autoimmunity. Seminars in Immunology, 18, 214.
7. Heward, J.M., Brand, O.J., Barrett, J.C., Carr-Smith, J.D., Franklyn, J.A. & Gough, S.C. (2007) Association of PTPN22 haplotypes with Grave's disease. Journal of Clinical Endocrinology and Metabolism, 92, 685.
8. Lea, W.W. & Lee, Y.H. (2010) The association between the PTPN22 C1858T polymorphism and systemic lupus erythematosus: a meta-analysis update. Lupus, 20, 51.
9. Lee, Y.H., Rho, H.Y., Choi, S.J., Ji, J.D., Song, G.G., Nath, S.K. et al. (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases - a meta-analysis. Rheumatology (Oxford), 46, 49.
10. Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R. et al. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. Journal of Thrombosis and Haemostasis, 4, 295.
11. Viken, M.K., Amundsen, S.S., Kvien, T.K., Boberg, K.M., Gilboe, I.M., Lilleby, V. et al. (2005) Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes and Immunity, 6, 271.